Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 530

1.

Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.

Kim JH, Lee JM, Park JH, Kim SC, Joo I, Han JK, Choi BI.

Radiology. 2013 Jan;266(1):185-96. doi: 10.1148/radiol.12120111. Epub 2012 Nov 28.

PMID:
23192779
2.

Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.

Akisik MF, Sandrasegaran K, Bu G, Lin C, Hutchins GD, Chiorean EG.

Radiology. 2010 Aug;256(2):441-9. doi: 10.1148/radiol.10091733. Epub 2010 Jun 1.

PMID:
20515976
3.

Free-breathing dynamic contrast-enhanced MRI of the abdomen and chest using a radial gradient echo sequence with K-space weighted image contrast (KWIC).

Kim KW, Lee JM, Jeon YS, Kang SE, Baek JH, Han JK, Choi BI, Bang YJ, Kiefer B, Block KT, Ji H, Bauer S, Kim C.

Eur Radiol. 2013 May;23(5):1352-60. doi: 10.1007/s00330-012-2699-4. Epub 2012 Nov 28.

PMID:
23187728
4.

Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.

Heye T, Davenport MS, Horvath JJ, Feuerlein S, Breault SR, Bashir MR, Merkle EM, Boll DT.

Radiology. 2013 Mar;266(3):801-11. doi: 10.1148/radiol.12120278. Epub 2012 Dec 6.

PMID:
23220897
5.

Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.

Manka C, Träber F, Gieseke J, Schild HH, Kuhl CK.

Radiology. 2005 Mar;234(3):869-77. Epub 2005 Jan 21.

PMID:
15665227
6.

Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.

Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.

AJR Am J Roentgenol. 2007 Oct;189(4):849.

PMID:
17885055
7.

Pancreas and peripancreatic vessels: effect of imaging delay on gadolinium enhancement at dynamic gradient-recalled-echo MR imaging.

Kanematsu M, Shiratori Y, Hoshi H, Kondo H, Matsuo M, Moriwaki H.

Radiology. 2000 Apr;215(1):95-102.

PMID:
10751473
8.

Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience.

Baxter S, Wang ZJ, Joe BN, Qayyum A, Taouli B, Yeh BM.

J Magn Reson Imaging. 2009 Jun;29(6):1317-22. doi: 10.1002/jmri.21795.

PMID:
19472388
9.

Evaluation of pancreatic cancer by multiple breath-hold dynamic contrast-enhanced magnetic resonance imaging at 3.0T.

Yao X, Zeng M, Wang H, Sun F, Rao S, Ji Y.

Eur J Radiol. 2012 Aug;81(8):e917-22. doi: 10.1016/j.ejrad.2012.05.011. Epub 2012 Jun 12.

PMID:
22695786
10.

Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.

Oto A, Fan X, Mustafi D, Jansen SA, Karczmar GS, Rubin DT, Kayhan A.

Acad Radiol. 2009 Oct;16(10):1223-30. doi: 10.1016/j.acra.2009.04.010. Epub 2009 Jun 12.

PMID:
19524458
11.

Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.

Bali MA, Metens T, Denolin V, Delhaye M, Demetter P, Closset J, Matos C.

Radiology. 2011 Nov;261(2):456-66. doi: 10.1148/radiol.11103515. Epub 2011 Aug 18.

PMID:
21852570
13.

Enhancing fraction in glioma and its relationship to the tumoral vascular microenvironment: A dynamic contrast-enhanced MR imaging study.

Mills SJ, Soh C, O'Connor JP, Rose CJ, Buonaccorsi G, Cheung S, Zhao S, Parker GJ, Jackson A.

AJNR Am J Neuroradiol. 2010 Apr;31(4):726-31. doi: 10.3174/ajnr.A1925. Epub 2009 Dec 17.

14.

Dynamic contrast-enhanced MRI of gastric cancer: Correlation of the perfusion parameters with pathological prognostic factors.

Joo I, Lee JM, Han JK, Yang HK, Lee HJ, Choi BI.

J Magn Reson Imaging. 2015 Jun;41(6):1608-14. doi: 10.1002/jmri.24711. Epub 2014 Jul 16.

PMID:
25044978
15.

Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.

Sung YS, Kwon HJ, Park BW, Cho G, Lee CK, Cho KS, Kim JK.

AJR Am J Roentgenol. 2011 Nov;197(5):1122-9. doi: 10.2214/AJR.10.6062.

PMID:
22021504
16.

Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: model selection, reproducibility, and validation.

Gaens ME, Backes WH, Rozel S, Lipperts M, Sanders SN, Jaspers K, Cleutjens JP, Sluimer JC, Heeneman S, Daemen MJ, Welten RJ, Daemen JW, Wildberger JE, Kwee RM, Kooi ME.

Radiology. 2013 Jan;266(1):271-9. doi: 10.1148/radiol.12120499. Epub 2012 Nov 14.

PMID:
23151823
17.

Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.

Mendichovszky IA, Cutajar M, Gordon I.

Eur J Radiol. 2009 Sep;71(3):576-81. doi: 10.1016/j.ejrad.2008.09.025. Epub 2008 Nov 11.

PMID:
19004588
18.
19.

Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.

Kim KA, Kim MJ, Park MS, Lim JS, Choi JY, Hong HS, Kim KW.

Radiology. 2010 Aug;256(2):475-84. doi: 10.1148/radiol.10091774.

PMID:
20656837
20.

Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.

Gokalp G, Topal U, Yildirim N, Tolunay S.

Eur J Radiol. 2012 Feb;81(2):203-8. doi: 10.1016/j.ejrad.2010.12.022. Epub 2011 Jan 13.

PMID:
21236612

Supplemental Content

Support Center